TCTCN™ (Transplantation and Cellular
Therapy Certified Nurse) WITH
CORRECT ACTUAL QUESTIONS AND
CORRECTLY WELL DEFINED ANSWERS
LATEST ALREADY GRADED A+
(2025/2026)
Domain 1: Foundations of Transplant (Questions 1-30)
Question 1
The primary goal of hematopoietic stem cell transplantation (HSCT) is to:
A) Treat opportunistic infections
B) Replace diseased bone marrow with healthy stem cells
C) Provide lifelong immunosuppressive therapy
D) Reduce the side effects of chemotherapy
Correct ,,,,Answer,,,,: B) Replace diseased bone marrow with healthy
stem cells ✅
Rationale: HSCT aims to restore normal hematopoiesis by replacing
defective or diseased marrow with healthy donor or autologous stem
cells. This restores the patient's ability to produce healthy blood cells and,
in malignant diseases, provides a graft-versus-malignancy effect .
,Question 2
Which of the following represents the most significant change to the
BMTCN examination beginning in January 2026?
A) The elimination of all questions about graft-versus-host disease
B) The name change to TCTCN™ and increased cellular therapy content
C) Reduced eligibility requirements for RN licensure
D) A new requirement for 5,000 practice hours instead of 2,000
Correct ,,,,Answer,,,,: B) The name change to TCTCN™ and increased
cellular therapy content ✅
Rationale: Effective January 2026, the BMTCN® examination has been
renamed to TCTCN™ (Transplantation and Cellular Therapy Certified
Nurse). The test content outline has been updated to include more
questions about cellular therapy, reflecting the evolution of transplant
and cellular therapy nursing practice .
Question 3
A nurse is explaining the concept of "graft-versus-tumor" (GVT) effect to a
patient. Which statement best describes this phenomenon?
A) The patient's tumor cells attack the donor stem cells
B) Donor immune cells recognize and eliminate residual malignant cells
C) Chemotherapy drugs target both tumor and normal cells
D) The transplanted stem cells fail to produce healthy blood cells
,Correct ,,,,Answer,,,,: B) Donor immune cells recognize and eliminate
residual malignant cells ✅
Rationale: The graft-versus-tumor (GVT) effect occurs when
immunologically competent donor T cells recognize residual malignant
cells as foreign and mount an immune response against them. This
beneficial effect is a key reason allogeneic transplantation can cure
diseases refractory to chemotherapy alone .
Question 4
Which type of transplant carries the HIGHEST risk of graft-versus-host
disease (GVHD)?
A) Autologous transplant
B) Syngeneic transplant (identical twin)
C) Allogeneic transplant from an HLA-matched sibling
D) Allogeneic transplant from an HLA-matched unrelated donor
Correct ,,,,Answer,,,,: D) Allogeneic transplant from an HLA-matched
unrelated donor ✅
Rationale: All unrelated donor transplants carry higher GVHD risk than
sibling-matched transplants due to minor histocompatibility antigen
mismatches. Autologous and syngeneic (identical twin) transplants have
no GVHD risk .
, Question 5
A nurse is preparing a patient for an autologous stem cell transplant.
Which statement accurately describes this type of transplant?
A) Stem cells come from an HLA-matched sibling donor
B) Stem cells come from the patient themselves
C) Stem cells come from an unrelated donor
D) There is a high risk of GVHD
Correct ,,,,Answer,,,,: B) Stem cells come from the patient themselves
✅
Rationale: Autologous transplants use the patient's own stem cells,
which are collected, cryopreserved, and reinfused after high-dose
therapy. This eliminates GVHD risk while allowing dose-intensive
treatment .
Question 6
The administration of Epstein-Barr virus (EBV) cytotoxic T-lymphocytes
has been found to be a feasible therapeutic option in which EBV-mediated
disease process?
A) Neuroblastoma
B) Lymphoproliferative disease
C) Nasopharyngeal rhabdomyosarcoma
D) Acute lymphocytic leukemia
Correct ,,,,Answer,,,,: B) Lymphoproliferative disease ✅
Rationale: Clinical studies have demonstrated the feasibility and safety of
administering EBV-specific cytotoxic T-lymphocytes to prevent and treat
Therapy Certified Nurse) WITH
CORRECT ACTUAL QUESTIONS AND
CORRECTLY WELL DEFINED ANSWERS
LATEST ALREADY GRADED A+
(2025/2026)
Domain 1: Foundations of Transplant (Questions 1-30)
Question 1
The primary goal of hematopoietic stem cell transplantation (HSCT) is to:
A) Treat opportunistic infections
B) Replace diseased bone marrow with healthy stem cells
C) Provide lifelong immunosuppressive therapy
D) Reduce the side effects of chemotherapy
Correct ,,,,Answer,,,,: B) Replace diseased bone marrow with healthy
stem cells ✅
Rationale: HSCT aims to restore normal hematopoiesis by replacing
defective or diseased marrow with healthy donor or autologous stem
cells. This restores the patient's ability to produce healthy blood cells and,
in malignant diseases, provides a graft-versus-malignancy effect .
,Question 2
Which of the following represents the most significant change to the
BMTCN examination beginning in January 2026?
A) The elimination of all questions about graft-versus-host disease
B) The name change to TCTCN™ and increased cellular therapy content
C) Reduced eligibility requirements for RN licensure
D) A new requirement for 5,000 practice hours instead of 2,000
Correct ,,,,Answer,,,,: B) The name change to TCTCN™ and increased
cellular therapy content ✅
Rationale: Effective January 2026, the BMTCN® examination has been
renamed to TCTCN™ (Transplantation and Cellular Therapy Certified
Nurse). The test content outline has been updated to include more
questions about cellular therapy, reflecting the evolution of transplant
and cellular therapy nursing practice .
Question 3
A nurse is explaining the concept of "graft-versus-tumor" (GVT) effect to a
patient. Which statement best describes this phenomenon?
A) The patient's tumor cells attack the donor stem cells
B) Donor immune cells recognize and eliminate residual malignant cells
C) Chemotherapy drugs target both tumor and normal cells
D) The transplanted stem cells fail to produce healthy blood cells
,Correct ,,,,Answer,,,,: B) Donor immune cells recognize and eliminate
residual malignant cells ✅
Rationale: The graft-versus-tumor (GVT) effect occurs when
immunologically competent donor T cells recognize residual malignant
cells as foreign and mount an immune response against them. This
beneficial effect is a key reason allogeneic transplantation can cure
diseases refractory to chemotherapy alone .
Question 4
Which type of transplant carries the HIGHEST risk of graft-versus-host
disease (GVHD)?
A) Autologous transplant
B) Syngeneic transplant (identical twin)
C) Allogeneic transplant from an HLA-matched sibling
D) Allogeneic transplant from an HLA-matched unrelated donor
Correct ,,,,Answer,,,,: D) Allogeneic transplant from an HLA-matched
unrelated donor ✅
Rationale: All unrelated donor transplants carry higher GVHD risk than
sibling-matched transplants due to minor histocompatibility antigen
mismatches. Autologous and syngeneic (identical twin) transplants have
no GVHD risk .
, Question 5
A nurse is preparing a patient for an autologous stem cell transplant.
Which statement accurately describes this type of transplant?
A) Stem cells come from an HLA-matched sibling donor
B) Stem cells come from the patient themselves
C) Stem cells come from an unrelated donor
D) There is a high risk of GVHD
Correct ,,,,Answer,,,,: B) Stem cells come from the patient themselves
✅
Rationale: Autologous transplants use the patient's own stem cells,
which are collected, cryopreserved, and reinfused after high-dose
therapy. This eliminates GVHD risk while allowing dose-intensive
treatment .
Question 6
The administration of Epstein-Barr virus (EBV) cytotoxic T-lymphocytes
has been found to be a feasible therapeutic option in which EBV-mediated
disease process?
A) Neuroblastoma
B) Lymphoproliferative disease
C) Nasopharyngeal rhabdomyosarcoma
D) Acute lymphocytic leukemia
Correct ,,,,Answer,,,,: B) Lymphoproliferative disease ✅
Rationale: Clinical studies have demonstrated the feasibility and safety of
administering EBV-specific cytotoxic T-lymphocytes to prevent and treat
